Urai Shin, Bando Hironori, Nakatsuji Mei, Yamamoto Masaaki, Fukuoka Hidenori, Iguchi Genzo, Ogawa Wataru
Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Hospital, Kobe, Japan.
Endocrinol Diabetes Metab Case Rep. 2024 Sep 19;2024(3). doi: 10.1530/EDM-23-0129. Print 2024 Jul 1.
A 52-year-old female patient with breast cancer presented with a history of fatigue and malaise 1 year prior. She was diagnosed with isolated adrenocorticotropic hormone (ACTH) deficiency (IAD) on endocrinological examination. Her pituitary gland showed normal morphology. Paraneoplastic IAD associated with breast cancer was suspected; however, immunofluorescence staining revealed no ectopic ACTH or proopiomelanocortin expression in the tumor tissue. Subsequently, the patient was diagnosed with idiopathic acquired IAD concurrent with breast cancer, ruling out paraneoplastic syndrome. Although malignancy should be considered a potential cause of IAD, not all patients with concurrent IAD and malignancy necessarily develop paraneoplastic syndrome.
Several adrenal insufficiency symptoms are similar to the nonspecific symptoms associated with malignancies, and therefore, the diagnosis of IAD remains challenging, especially in patients with cancer. When we encounter a case of IAD accompanied by a malignant tumor, it is important to suspect that paraneoplastic IAD, a novel clinical condition as secondary hypophysitis, may be the etiologic agent. Although malignant tumours should be considered a potential cause of IAD, not all patients with concurrent IAD and malignancy necessarily develop paraneoplastic autoimmune hypophysitis.
一名52岁乳腺癌女性患者,1年前出现疲劳和不适病史。内分泌检查诊断为孤立性促肾上腺皮质激素(ACTH)缺乏症(IAD)。其垂体形态正常。怀疑为与乳腺癌相关的副肿瘤性IAD;然而,免疫荧光染色显示肿瘤组织中无异位ACTH或阿片促黑素皮质素原表达。随后,该患者被诊断为特发性获得性IAD并发乳腺癌,排除了副肿瘤综合征。虽然恶性肿瘤应被视为IAD的潜在病因,但并非所有同时患有IAD和恶性肿瘤的患者都会发生副肿瘤综合征。
几种肾上腺功能不全症状与恶性肿瘤相关的非特异性症状相似,因此,IAD的诊断仍然具有挑战性,尤其是在癌症患者中。当我们遇到一例伴有恶性肿瘤的IAD病例时,重要的是怀疑副肿瘤性IAD,一种作为继发性垂体炎的新型临床病症,可能是病因。虽然恶性肿瘤应被视为IAD的潜在病因,但并非所有同时患有IAD和恶性肿瘤的患者都会发生副肿瘤性自身免疫性垂体炎。